Potential Role of FDG-PET-CT in Assessing Cardio-Vascular-Pulmonary CNS and Other Complications of COVID-19 Infection
Enrolling By Invitation
18 years - 99 years
All
Phase
N/A
20 participants needed
1 Location
Brief description of study
The research study is being conducted to assess the role of Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) imaging (a radiology scan) for monitoring the course of COVID-19 infection.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: COVID-19
-
Age: 18 years - 99 years
-
Gender: All
Male and Female 18 years of age or older
Updated on
04 Aug 2024.
Study ID: 844295
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
